Breaking News Instant updates and real-time market news.

LITE

Lumentum

$55.30

-0.75 (-1.34%)

, FNSR

Finisar

$22.06

-0.1 (-0.45%)

09:02
10/06/17
10/06
09:02
10/06/17
09:02

Jefferies boosts Lumentum target to $75 on 3D sensing opportunity

After speaking to contacts and building an industry model, Jefferies analyst James Kisner believes investors may be underestimating the longer-term impact to earnings from 3D sensing, particularly for Lumentum (LITE), given its market leadership. The analyst's base case has the revenue opportunity for lasers and filters for 3D sensing ramping from $31M in 2017 to $1B in 2018 and $3.5B in 2023. Lumentum is the biggest beneficiary of 3D sensing as Finisar (FNSR) is capacity limited and Viavi's (VIAV) filters have relatively low average selling prices, Kisner tells investors in a research note. He raised his estimates for Lumentum while modestly lowering numbers for Finisar and Viavi. The analyst also boosted his price target for Lumentum to $75 from $72. Kisner has Buy ratings on all three names.

LITE

Lumentum

$55.30

-0.75 (-1.34%)

FNSR

Finisar

$22.06

-0.1 (-0.45%)

VIAV

Viavi

$9.51

-0.06 (-0.63%)

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

LITE Lumentum
$55.30

-0.75 (-1.34%)

10/04/17
RSBL
10/04/17
NO CHANGE
RSBL
Lumentum mentioned positively at Rosenblatt
09/27/17
MKMP
09/27/17
UPGRADE
MKMP
Buy
Lumentum upgraded to Buy from Neutral at MKM Partners
09/27/17
MKMP
09/27/17
UPGRADE
MKMP
Buy
Lumentum upgraded on valuation, checks at MKM Partners
As noted earlier, MKM Partners upgraded Lumentum to Buy from Neutral. Analyst Michael Genovese upgraded the stock based on valuation and his checks which lead him to believe that orders for the 3D Sensing product "rose significantly"since it reported its results on August 9. The analyst says that the company is the only optical components company that looks poised to deliver beat and raise results "in the near-term.: Target $66.
09/27/17
09/27/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Darden (DRI) was upgraded to Buy from Hold at Maxim and to Outperform from Neutral at Baird. 2. Michael Kors (KORS) upgraded to Buy from Hold at Canaccord with analyst Camilo Lyon saying he believes the strategic steps management has recently begun implementing are showing signs of traction. 3. RBS (RBS) upgraded to Buy from Hold at Jefferies. 4. Lumentum (LITE) upgraded to Buy from Neutral at MKM Partners with analyst Michael Genovese citing valuation and his checks which lead him to believe that orders for the 3D Sensing product "rose significantly"since it reported its results on August 9. 5. Telefonica (TEF) upgraded to Buy from Hold at Berenberg. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
FNSR Finisar
$22.06

-0.1 (-0.45%)

09/08/17
NEED
09/08/17
NO CHANGE
NEED
Finisar price target lowered to $34 from $44 at Needham
Needham analyst Alex Henderson lowered his price target on Finisar after the company cut its Q3 guidance. However, he keeps a Strong Buy rating on the stock.
09/17/17
PIPR
09/17/17
NO CHANGE
Target $26
PIPR
Overweight
Finisar has catalysts to help accelerate growth, says Piper Jaffray
Piper Jaffray analyst Troy Jensen recommends investors revisit Finisar shares as he believes the optical group will likely experience accelerating growth in 2018 and believes Finisar has some company specific catalysts to help accelerate growth. The analyst believes China demand will improve by year-end and into 2018 with inventor levels being reduced and new China tenders helping grow demand. Jensen also believes Finisar will see VCSEL sales start an impressive ramp in October, coupled with initial revenues for the CFP2-ACO qualification at Cisco in the January quarter followed by ROADM line cards in the April quarter. This growth recovery coupled with lowered assumptions and valuation creates an "attractive entry point," he contends. The analyst reiterates an Overweight rating and $26 price target on the shares.
09/08/17
CHLM
09/08/17
NO CHANGE
Target $28
CHLM
Buy
Finisar price target lowered to $28 from $38 at Craig-Hallum
Craig-Hallum analyst Richard Shannon Finisar's Q2 guidance was "quite poor," though he sees temporary factors far offsetting cyclical factors in October and thinks these should reverse in the near-future. The company blamed a manufacturing process tweak for pushing out 3D sensor sales by a quarter, but Shannon does not think this implies lost share with its lead customer, he tells investors. The analyst lowered his price target on Finisar shares to $28 from $38 but keeps his Buy rating on the stock.
09/08/17
MKMP
09/08/17
NO CHANGE
MKMP
Finisar catlysts just 'delayed,' not 'canceled,' says MKM Partners
After Finisar's Q2 guidance came in well below expectations, MKM Partners analyst Michael Genovese says that "all of the meaningful catalysts for the stock are delayed, but none are canceled." He says that "the most important catalyst," 3D Sensing, "is only delayed by one quarter," while two other positive catalysts - "full Verizon qualification and demand recovery in China" - "are delayed by 1-2 quarters." He trimmed his price target on the name to $31 from $33 but keeps a Buy rating on the stock.
VIAV Viavi
$9.51

-0.06 (-0.63%)

05/05/17
JEFF
05/05/17
UPGRADE
Target $14
JEFF
Buy
Viavi upgraded to Buy from Hold at Jefferies
Jefferies analyst James Kisner upgraded Viavi Solutions (VIAV) to Buy saying the company's 3D sensing opportunity will "significantly increase" its earnings growth rate. The analyst expects Apple (AAPL) to launch an iPhone with 3D sensing in 2017, with multiple smartphone markers following suit in 2018. Viavi will remain the industry's sole supplier for the filter, the analyst contends. He upped his price target for the shares to $14 from $9.50.
05/09/17
DADA
05/09/17
DOWNGRADE
Target $40
DADA
Neutral
Gigamon downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Mark Kelleher downgraded Gigamon to Neutral citing valuation following the recent rally. The analyst believes a sale of the company will be high on the strategic alternatives list for new activist investor Elliott Management. He lists Viavi (VIAV) and NetScout (NTCT) as possible acquirers. Should a deal happen, Kelleher expects a "lack of take-out premium." He raised his price target for Gigamon to $40.
05/22/17
RSBL
05/22/17
NO CHANGE
RSBL
China Telecom has begun work on Metro upgrade plan, says Rosenblatt
Rosenblatt Securities said China Telecom (CHA) has begun work on its Metro upgrade plan and the firm believes it will release tenders for both provincial and Metro in the timeframe of September to October. Companies in the optical equipment space that could benefit from China's upgrade cycle include Oclaro (OCRL), Finisar (FNSR), Lumentum (LITE), NeoPhotonics (NPTN), Acacia Communications (ACIA) and Viavi (VIAV).
07/21/17
RILY
07/21/17
UPGRADE
Target $14
RILY
Buy
Viavi upgraded to Buy from Neutral at B. Riley
B. Riley analyst Dave Kang upgraded Viavi to Buy and raised his price target for the shares to $14 from $8.75. The analyst believes telecom demand is starting to improve and thinks the company's 3D sensing will drive top-line growth and margin expansion.

TODAY'S FREE FLY STORIES

03:45
10/20/17
10/20
03:45
10/20/17
03:45
General news
FX Action: USD-CAD has rallied back above 1.2500 »

FX Action: USD-CAD has…

02:55
10/20/17
10/20
02:55
10/20/17
02:55
General news
FX Update: The dollar has rallied across the board »

FX Update: The dollar…

01:45
10/20/17
10/20
01:45
10/20/17
01:45
General news
Breaking General news story  »

Federal Reserve Chair…

STLD

Steel Dynamics

$37.78

1.34 (3.68%)

21:35
10/19/17
10/19
21:35
10/19/17
21:35
Upgrade
Steel Dynamics rating change at KeyBanc »

Steel Dynamics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

RXDX

Ignyta

$16.65

0.4 (2.46%)

20:30
10/19/17
10/19
20:30
10/19/17
20:30
Syndicate
Ignyta 10M share Secondary priced at $16.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 20

    Oct

PG

Procter & Gamble

$91.59

-0.4904 (-0.53%)

, GE

General Electric

$23.58

0.46 (1.99%)

20:25
10/19/17
10/19
20:25
10/19/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$91.59

-0.4904 (-0.53%)

GE

General Electric

$23.58

0.46 (1.99%)

HON

Honeywell

$143.62

0.18 (0.13%)

SLB

Schlumberger

$64.50

-1.41 (-2.14%)

STI

SunTrust

$59.11

-0.18 (-0.30%)

SYF

Synchrony

$31.71

0.2 (0.63%)

CFG

Citizens Financial

$37.43

0.25 (0.67%)

KSU

Kansas City Southern

$103.78

0.97 (0.94%)

GNTX

Gentex

$20.66

0.2 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 02

    Nov

WILC

G. Willi-Food

$5.85

-0.14 (-2.34%)

18:35
10/19/17
10/19
18:35
10/19/17
18:35
Hot Stocks
G. Willi-Food receives notice from Arla Food ending distribution agreement »

G. Willi-Food's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$71.26

-0.46 (-0.64%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Macquarie Infrastructure CEO to become CEO of Macquarie Atlas Roads in 2018 »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

BIDU

Baidu

$264.52

-4.45 (-1.65%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Baidu collaborating with China's BAIC Group and King Long for autonomous driving »

Baidu signed strategic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

IBKC

Iberiabank

$80.15

0.05 (0.06%)

18:27
10/19/17
10/19
18:27
10/19/17
18:27
Hot Stocks
IBERIABANK to acquire Gibraltar Private Bank & Trust »

IBERIABANK Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 15

    Nov

  • 28

    Nov

VBTX

Veritex

$27.04

-0.02 (-0.07%)

18:20
10/19/17
10/19
18:20
10/19/17
18:20
Hot Stocks
Veritex receives regulatory approval for Liberty Bancshares merger »

Veritex Holdings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BHP

BHP Billiton

$41.56

0.06 (0.14%)

18:03
10/19/17
10/19
18:03
10/19/17
18:03
Hot Stocks
BHP Billiton CEO sees challenges around geopolitical uncertainty remaining »

In annual shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRRX

Durect

$1.97

0.03 (1.55%)

17:59
10/19/17
10/19
17:59
10/19/17
17:59
Hot Stocks
Durect: Phase 3 clinical trial for POSIMIR did not meet primary endpoint »

Durect reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTNP

Titan Pharmaceuticals

$1.90

-0.1 (-5.00%)

17:49
10/19/17
10/19
17:49
10/19/17
17:49
Hot Stocks
Titan Pharmaceuticals presents non-clinical data from liothyronine implant »

Titan Pharmaceuticals is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSA

MSA Safety

$82.20

1.37 (1.69%)

17:46
10/19/17
10/19
17:46
10/19/17
17:46
Earnings
MSA Safety reports Q3 EPS 92c, consensus 80c »

Reports Q3 revenue $296M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

SKX

Skechers

$24.03

-1.06 (-4.22%)

, CAI

CAI International

$31.38

-0.05 (-0.16%)

17:41
10/19/17
10/19
17:41
10/19/17
17:41
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SKX

Skechers

$24.03

-1.06 (-4.22%)

CAI

CAI International

$31.38

-0.05 (-0.16%)

PYPL

PayPal

$67.25

-0.01 (-0.01%)

MXIM

Maxim Integrated

$50.09

0.24 (0.48%)

IMDZ

Immune Design

$5.50

-1.05 (-16.03%)

NCR

NCR Corp.

$37.05

-0.26 (-0.70%)

TACO

Del Taco

$15.39

-0.01 (-0.06%)

ATHN

athenahealth

$116.41

-4.37 (-3.62%)

ISRG

Intuitive Surgical

$357.46

3.09 (0.87%)

ETFC

E-Trade

$43.69

-0.23 (-0.52%)

CELG

Celgene

$135.96

-1.21 (-0.88%)

PBMD

Prima BioMed

$2.36

-0.02 (-0.84%)

AAXN

Axon

$24.62

-0.37 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 21

    Oct

  • 22

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 29

    Nov

DGX

Quest Diagnostics

$93.23

1.18 (1.28%)

17:37
10/19/17
10/19
17:37
10/19/17
17:37
Hot Stocks
Quest Diagnostics acquires Cleveland HeartLab, terms not disclosed »

Advantage Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

  • 30

    Nov

AAXN

Axon

$24.62

-0.37 (-1.48%)

17:34
10/19/17
10/19
17:34
10/19/17
17:34
Hot Stocks
Axon says now aware of comment letter over SEC's review of 10-K, 10-Q »

Axon Enterprise said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMX

BioPharmX

17:29
10/19/17
10/19
17:29
10/19/17
17:29
Syndicate
Breaking Syndicate news story on BioPharmX »

BioPharmX files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBVX

MabVax Therapeutics

$0.74

0.0248 (3.47%)

17:29
10/19/17
10/19
17:29
10/19/17
17:29
Syndicate
Breaking Syndicate news story on MabVax Therapeutics »

MabVax Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

Iberiabank

$80.15

0.05 (0.06%)

17:28
10/19/17
10/19
17:28
10/19/17
17:28
Earnings
Iberiabank reports Q3 non-GAAP EPS $1.00, consensus $1.16 »

Reports Q3 core revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 15

    Nov

  • 28

    Nov

DRRX

Durect

$1.97

0.03 (1.55%)

17:28
10/19/17
10/19
17:28
10/19/17
17:28
Hot Stocks
Breaking Hot Stocks news story on Durect »

Durect trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCP

Quality Care Properties

$16.26

0.07 (0.43%)

17:26
10/19/17
10/19
17:26
10/19/17
17:26
Hot Stocks
Quality Care Properties provides update on HCR ManorCare »

Quality Care Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTR

Frontier Communications

$11.48

0.02 (0.17%)

, CHH

Choice Hotels

$68.45

0.25 (0.37%)

17:26
10/19/17
10/19
17:26
10/19/17
17:26
Hot Stocks
Frontier Communications named a Qualified Vendor with Choice Hotels Internationa »

Frontier Communications…

FTR

Frontier Communications

$11.48

0.02 (0.17%)

CHH

Choice Hotels

$68.45

0.25 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 08

    Nov

DRIO

DarioHealth

$1.98

-0.2 (-9.17%)

17:16
10/19/17
10/19
17:16
10/19/17
17:16
Syndicate
Breaking Syndicate news story on DarioHealth  »

DarioHealth files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.